Profilo
Heather Dale Jones is currently working as an Associate Clinical Professor at David Geffen School of Medicine.
Previously, she worked as the Director-Lung Imaging & Associate Professor at Cedars-Sinai Medical Center and as the Vice President-Clinical Development at Armata Pharmaceuticals, Inc. Dr. Jones completed her undergraduate degree at the University of California, Berkeley and her doctorate at Hahnemann University.
Posizioni attive di Heather Dale Jones
| Società | Posizione | Inizio |
|---|---|---|
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Heather Dale Jones
| Società | Posizione | Fine |
|---|---|---|
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
| ARMATA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Heather Dale Jones
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hahnemann University
Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
















